NCT07259876Not yet recruiting
Efficacy of a Bilateral Robotic Treatment in Chronic Patients
Efficacy and Neurophysiological Correlates of a Bilateral Robotic Treatment for the Upper Limbs in Patients With Chronic Stroke Outcomes
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate how manual dominance influences the effectiveness of bilateral robotic treatment in right-handed patients with chronic stroke. Researchers will compare the outcome of a bilateral robotic treatment for the upper limbs in left vs right hemisphere lesions following stroke. Participants will: * perform a bilateral robotic treatment for the upper limb (15 sessions in three weeks) followed by 20-minutes standard manual rehabilitative sessions * be evaluated before and after treatment with clinical scales, resting- state EEG and kinematic measurements
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- Jul 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- University of Pisa
- Diseases
- Stroke
- NCT number
- NCT07259876
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Jul 2026 to the primary completion date, Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Subjects with cognitive deficits that impair understanding of the required tasks (MMSE score corrected for age and education \< 24/30)
Other
- Subjects with severe visual deficits
- Subjects with upper limb spasticity preventing the use of robotic devices (spasticity measured using the Modified Ashworth Scale \> 3)
- Inability or unwillingness to provide informed consent
- Left-handed subjects
Who the study is looking for
- Subjects aged between 18 and 80 years, of either sex
- Subjects able to understand and provide, or have provided on their behalf, informed consent
- History of a single unilateral ischemic or hemorrhagic cerebrovascular event in the chronic phase (\> 6 months)
- Subjects with mild to moderate functional impairment of the right or left upper limb (ability to perform antigravity active movements)
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.